These data are in line with cell line database analyses demonstrating downregulation of PRELP expression in skin cancer cells (log2FC = − 0.77 and p < 0.031) when compared to their normal counterparts, such as melanocytes and keratinocytes (GENT2—skin cancer cell lines) (Fig. 1B). This evidence concerns the gene PRELP and skin neoplasm.